Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Novartis Interest Could Scuttle Crucell's Bid For Berna Biotech

Dec. 28, 2005

By Cormac Sheridan

Santhera Brings In CHF25M, Starts Idebenone Pivotal Trial

Dec. 21, 2005

By Cormac Sheridan

Santhera Brings In CHF25M, Starts Idebenone Pivotal Trial

Dec. 21, 2005

By Cormac Sheridan

Zealand Pharma Learning Lessons From Pulled IPO

Dec. 14, 2005

By Cormac Sheridan

Cellartis Brings In EUR 8M For Embryonic Stem Cell Work

Dec. 14, 2005

By Cormac Sheridan

Zealand Pharma Learning Lessons From Pulled IPO

Dec. 14, 2005

By Cormac Sheridan

Cellartis Brings In EUR 8M For Embryonic Stem Cell Work

Dec. 14, 2005

By Cormac Sheridan

Crucell Buying Berna Biotech In $449M All-Share Takeover

Dec. 7, 2005

By Cormac Sheridan

Crucell Buying Berna Biotech In $449M All-Share Takeover

Dec. 7, 2005

By Cormac Sheridan

Crucell Acquiring Berna Biotech In US$449M All-Share Takeover

Dec. 2, 2005

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...